Arcapta Neohaler
NDC Package 63402-675-06

The code 63402-675-06 identifies a specific commercial package of 1 blister pack in 1 carton / 6 capsule in 1 blister pack (63402-675-02) of Arcapta Neohaler, labeled by Sunovion Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sunovion Pharmaceuticals Inc. on July 01, 2011. The current certification is valid through January 31, 2021.

Indacaterol is used to treat trouble breathing and wheezing due to a certain ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and/or emphysema). It is used if your breathing problems are not controlled with other medication (such as a quick-relief inhaler). Indacaterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Indacaterol is also known as a bronchodilator. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. This medication should not be used for severe/sudden breathing problems. Other medications, such as a quick-relief inhaler should be used instead of indacaterol for sudden breathing problems. This medication is not a substitute for corticosteroids (such as beclomethasone, fluticasone, prednisone). Indacaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as indacaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63402067506. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.